表紙:マルチプレックスアッセイの世界市場予測 ~2023年:製品(消耗品、機器)、タイプ(核酸、タンパク、細胞)、技術(フローサイトメトリー、蛍光検出)、用途(研究開発、診断)、エンドユーザー、地域別
市場調査レポート
商品コード
365315

マルチプレックスアッセイの世界市場予測 ~2023年:製品(消耗品、機器)、タイプ(核酸、タンパク、細胞)、技術(フローサイトメトリー、蛍光検出)、用途(研究開発、診断)、エンドユーザー、地域別

Multiplex Assays Market by Product (Consumables, Instruments), Type (Nucleic Acid, Protein, Cell), Technology (Flow Cytometry, Luminescence), Application (R&D, Diagnosis), End User - Global Forecast to 2023

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 144 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.10円
マルチプレックスアッセイの世界市場予測 ~2023年:製品(消耗品、機器)、タイプ(核酸、タンパク、細胞)、技術(フローサイトメトリー、蛍光検出)、用途(研究開発、診断)、エンドユーザー、地域別
出版日: 2018年06月07日
発行: MarketsandMarkets
ページ情報: 英文 144 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のマルチプレックスアッセイ市場は、2018年から2023年の調査期間を通じて7.5%のCAGR (複合年間成長率) で推移し、2018年には23億3,000万米ドル、2023年には33億5,000万米ドルに拡大することが予測されています。当市場の主な成長要因には、コンパニオン診断におけるマルチプレックスアッセイの使用や、シングルプレックスおよび従来型アッセイに勝るマルチプレックスアッセイの利点などが挙げられます。

当レポートでは、世界のマルチプレックスアッセイの市場を調査し、市場の概要、製品・タイプ・技術・用途・エンドユーザー・地域別の市場動向、市場規模の推移と予測、成長要因・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

FIGURE 12 MULTIPLEX ASSAYS MARKET

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 市場概要
  • 北米のマルチプレックスアッセイ市場:用途・国別
  • マルチプレックスアッセイ市場:製品・サービス別
  • 地域概要

第5章 マルチプレックスアッセイの世界市場:概要

  • イントロダクション
  • 市場力学
    • 促進要因
      • コンパニオン診断におけるマルチプレックスアッセイの使用
      • シングルプレックスおよび従来型アッセイに勝る利点
    • 抑制要因
      • マルチプレックスアッセイ機器の高額なコスト
      • 厳格な規制と規格
    • 市場機会
      • 分子診断およびタンパク質解析におけるバイオマーカーのバリデーション
      • 大量処理および自動システムのニーズ

第6章 マルチプレックスアッセイの世界市場:製品・サービス別

  • イントロダクション
  • 消耗品
  • 機器
  • 付属品
  • ソフトウェア・サービス

第7章 マルチプレックスアッセイの世界市場:タイプ別

  • イントロダクション
  • タンパク質ベース
    • プラナータンパク質アッセイ
    • ビーズタンパク質アッセイ
    • その他
  • 核酸ベース
    • プラナー核酸アッセイ
    • ビーズ核酸アッセイ
    • その他
  • 細胞ベース

第8章 マルチプレックスアッセイの世界市場:技術別

  • イントロダクション
  • フローサイメトリー
  • 蛍光検出
  • 発光検出
  • マルチプレックスリアルタイムPRC
  • その他

第9章 マルチプレックスアッセイの世界市場:用途別

  • イントロダクション
  • 研究開発
    • 創薬・開発
    • バイオマーカーの発見とバリデーション
  • 臨床診断
    • 感染症
    • 心血管疾患
    • 自己免疫疾患
    • 神経系疾患
    • 代謝・内分泌系疾患
    • その他

第10章 マルチプレックスアッセイの世界市場:エンドユーザー別

  • イントロダクション
  • 製薬・バイオテクノロジー企業
  • 病院・研究機関
  • 基準測定施設
  • その他

第11章 マルチプレックスアッセイの世界市場:地域分析

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
  • アジア太平洋
  • その他の地域

第12章 競合環境

  • 概要
  • 市場ランキング分析
  • 競合情勢と動向
    • 製品の承認・上市
    • 提携・合意・協力
    • 買収

第13章 企業プロファイル

  • LUMINEX
  • THERMO FISHER SCIENTIFIC
  • ILLUMINA
  • BIO-RAD LABORATORIES
  • QIAGEN
  • ABCAM
  • BECTON DICKINSON AND COMPANY
  • MERCK
  • AGILENT TECHNOLOGIES
  • MESO SCALE DIAGNOSTICS
  • RANDOX LABORATORIES
  • QUANTERIX
  • BIO-TECHNE
  • OLINK
  • SEEGENE

第14章 付録

図表

LIST OF TABLES

  • TABLE 1: MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 2: MULTIPLEX ASSAY CONSUMABLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 3: NORTH AMERICA: MULTIPLEX ASSAY CONSUMABLES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 4: MULTIPLEX ASSAY INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 5: NORTH AMERICA: MULTIPLEX ASSAY INSTRUMENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 6: MULTIPLEX ASSAY SOFTWARE AND SERVICES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 7: NORTH AMERICA: MULTIPLEX ASSAY SOFTWARE AND SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 8: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 9: PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 10: PROTEIN MULTIPLEX ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 11: NORTH AMERICA: PROTEIN MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 12: PLANAR PROTEIN ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 13: NORTH AMERICA: PLANAR PROTEIN ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 14: BEAD-BASED PROTEIN ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 15: NORTH AMERICA: BEAD-BASED PROTEIN ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 16: OTHER PROTEIN ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 17: NORTH AMERICA: OTHER PROTEIN ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 18: NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 19: NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 20: NORTH AMERICA: NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 21: PLANAR NUCLEIC ACID ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 22: NORTH AMERICA: PLANAR NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 23: BEAD-BASED NUCLEIC ACID ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 24: NORTH AMERICA: BEAD-BASED NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 25: OTHER NUCLEIC ACID ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 26: NORTH AMERICA: OTHER NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 27: CELL-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 28: NORTH AMERICA: CELL-BASED MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 29: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 30: MULTIPLEX ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 31: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 32: MULTIPLEX ASSAYS MARKET FOR FLUORESCENCE DETECTION, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 33: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR FLUORESCENCE DETECTION, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 34: MULTIPLEX ASSAYS MARKET FOR LUMINESCENCE, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 35: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR LUMINESCENCE, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 36: MULTIPLEX ASSAYS MARKET FOR MULTIPLEX RT PCR, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 37: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR MULTIPLEX RT PCR, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 38: MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 39: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 40: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 41: MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 42: MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 43: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 44: MULTIPLEX ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 45: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 46: MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY & VALIDATION, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 47: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY & VALIDATION, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 48: MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 49: MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 50: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 51: MULTIPLEX ASSAYS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 52: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 53: MULTIPLEX ASSAYS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 54: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 55: MULTIPLEX ASSAYS MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 56: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CARDIAC DISEASE DIAGNOSTICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 57: MULTIPLEX ASSAYS MARKET FOR AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 58: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR AUTOIMMUNE DISEASE DIAGNOSTICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 59: MULTIPLEX ASSAYS MARKET FOR NERVOUS SYSTEM DISORDER DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 60: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR NERVOUS SYSTEM DISORDER DIAGNOSTICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 61: MULTIPLEX ASSAYS MARKET FOR METABOLISM & ENDOCRINOLOGY DISORDER DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 62: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR METABOLISM & ENDOCRINOLOGY DISORDER DIAGNOSTICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 63: MULTIPLEX ASSAYS MARKET FOR OTHER DISEASE DIAGNOSTICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 64: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER DISEASE DIAGNOSTICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 65: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 66: MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 67: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 68: MULTIPLEX ASSAYS MARKET FOR HOSPITALS & RESEARCH INSTITUTES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 69: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR HOSPITAL & RESEARCH INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 70: MULTIPLEX ASSAYS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 71: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 72: MULTIPLEX ASSAYS MARKET FOR OTHER END USERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 73: NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 74: MULTIPLEX ASSAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 75: NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 76: NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 77: NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 78: NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 79: NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 80: NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 81: US: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 82: US: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 83: US: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 84: US: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 85: US: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 86: CANADA: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 87: CANADA: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 88: CANADA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 89: CANADA: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 90: CANADA: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 91: EUROPE: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 92: EUROPE: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 93: EUROPE: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 94: EUROPE: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 95: EUROPE: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 96: ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 97: ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 98: ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 99: ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 100: ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 101: ROW: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 102: ROW: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 103: ROW: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 104: ROW: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 105: ROW: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 106: RANK OF COMPANIES IN THE MULTIPLEX ASSAYS MARKET, 2017
  • TABLE 107: PRODUCT LAUNCHES AND APPROVALS, 2015-2018
  • TABLE 108: COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2015-2018
  • TABLE 109: ACQUISITIONS, 2015-2018

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION
  • FIGURE 6: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 7: MULTIPLEX ASSAYS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 8: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2018 VS. 2023 (USD MILLION)
  • FIGURE 9: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: MULTIPLEX ASSAYS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT OF THE MULTIPLEX ASSAYS MARKET (2018-2023)
  • FIGURE 12: INCREASING ADOPTION OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS DRIVES THE GROWTH OF THE MARKET
  • FIGURE 13: R&D TO ACCOUNT FOR THE LARGEST SHARE OF THE MULTIPLEX ASSAYS MARKET IN NORTH AMERICA IN 2018
  • FIGURE 14: CONSUMABLES SEGMENT WILL CONTINUE TO DOMINATE THE MULTIPLEX ASSAYS MARKET IN 2023
  • FIGURE 15: APAC WILL BE THE FASTEST-GROWING MARKET FROM 2018 TO 2023
  • FIGURE 16: GLOBAL MULTIPLEX ASSAYS MARKET: DRIVERS, RESTRAINTS, & OPPORTUNITIES
  • FIGURE 17: GEOGRAPHIC SNAPSHOT: ASIA PACIFIC IS THE FASTEST-GROWING REGION IN THE GLOBAL MULTIPLEX ASSAYS MARKET
  • FIGURE 18: NORTH AMERICA: MULTIPLEX ASSAYS MARKET SNAPSHOT
  • FIGURE 19: ASIA PACIFIC: MULTIPLEX ASSAYS MARKET SNAPSHOT
  • FIGURE 20: KEY DEVELOPMENTS REGISTERED BY LEADING PLAYERS IN THE MULTIPLEX ASSAYS MARKET, 2015-2018
  • FIGURE 21: LUMINEX: COMPANY SNAPSHOT (2017)
  • FIGURE 22: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
  • FIGURE 23: ILLUMINA: COMPANY SNAPSHOT ( 2017)
  • FIGURE 24: BIO-RAD LABORATORIES: COMPANY SNAPSHOT ( 2017)
  • FIGURE 25: QIAGEN: COMPANY SNAPSHOT ( 2017)
  • FIGURE 26: ABCAM: COMPANY SNAPSHOT (2017)
  • FIGURE 27: BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT (2017)
  • FIGURE 28: MERCK: COMPANY SNAPSHOT (2017)
  • FIGURE 29: AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2017)
  • FIGURE 30: QUANTERIX: COMPANY SNAPSHOT (2017)
  • FIGURE 31: BIO-TECHNE: COMPANY SNAPSHOT (2017)
  • FIGURE 32: SEEGENE: COMPANY SNAPSHOT ( 2017)
目次
Product Code: BT 4473

"The global multiplex assays market is projected to grow at a CAGR of 7.5%."

The global multiplex assays market is projected to reach USD 3.35 billion in 2023 from USD 2.33 billion in 2018, at CAGR of 7.5%. Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay. The use of multiplex assays in companion diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays are driving the growth of the market. However, the high cost of multiplex assay equipment & standardization of immunoassay design and quality control are the major factors expected to restrain market growth.

"The pharmaceutical and biotechnology segment is expected to account for the largest share in 2018."

On the basis of end user, the global multiplex assays market is divided into pharmaceutical and biotechnology companies, hospitals & academic research institutes, reference laboratories, and other end users. In 2018, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the global multiplex assays market. This large share can be attributed to the increased adoption of multiplex assays in drug discovery & development by pharmaceuticals and the growing focus of biotechnology companies on developing biosimilars and monoclonal antibodies.

"North America is expected to account for the largest share of the market in 2018."

By geography, North America is expected to account for the largest share of the multiplex assays market in 2018, followed by Europe. The dominant share of North American market is primarily attributed to its established pharmaceutical industry, presence of leading pharmaceutical and biotechnology companies, and high R&D investment.

Break-up profile of primaries::

  • By Company Type- Tier 1-42%, Tier 2-37% and Tier 3-21%
  • By Designation- C-level-34%, D-level-42% and Others-24%
  • By Region- North America-32%, Europe-30%, Asia Pacific-24%, and RoW-14%

The key players in the multiplex assays market are: Luminex (US), Bio-Rad Laboratories (US), Becton, Dickinson (US), Illumina (US), and Thermo Fisher Scientific (US).

Research Coverage:

The multiplex assays market in this report is segmented by product & services, type, technology, application, and end user. The study tracks and analyzes competitive developments such as product launches, collaborations, agreements, partnerships, and acquisitions, and profiles key players and core competencies in the multiplex assays market.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on portfolios offered by the top players in the global multiplex assays market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global multiplex assays market
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the markets for multiplex assays products across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global multiplex assays market
  • Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global multiplex assays market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. PRIMARY DATA
    • 2.1.1. KEY DATA FROM PRIMARY SOURCES
    • 2.1.2. KEY INDUSTRY INSIGHTS
  • 2.2. SECONDARY DATA
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
  • 2.3. MARKET SIZE ESTIMATION
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.4.1. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. MULTIPLEX ASSAYS MARKET OVERVIEW
  • 4.2. NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY APPLICATION AND COUNTRY (2018)
  • 4.3. MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE (2018 VS. 2023)
  • 4.4. GEOGRAPHICAL SNAPSHOT OF THE MULTIPLEX ASSAYS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Use of multiplex assays in companion diagnostics
      • 5.2.1.2. Advantages over singleplex and traditional assays
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High equipment costs
      • 5.2.2.2. Stringent regulations and standards
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Increasing validation of biomarkers in molecular and protein diagnostics
      • 5.2.3.2. Need for high-throughput and automated systems

6. MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICE

  • 6.1. INTRODUCTION
  • 6.2. CONSUMABLES
  • 6.3. INSTRUMENTS
  • 6.4. SOFTWARE AND SERVICES

7. MULTIPLEX ASSAYS MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. PROTEIN MULTIPLEX ASSAYS
    • 7.2.1. PLANAR PROTEIN ASSAYS
    • 7.2.2. BEAD-BASED PROTEIN ASSAYS
    • 7.2.3. OTHER PROTEIN ASSAYS
  • 7.3. NUCLEIC ACID MULTIPLEX ASSAYS
    • 7.3.1. PLANAR NUCLEIC ACID ASSAYS
    • 7.3.2. BEAD-BASED NUCLEIC ACID ASSAYS
    • 7.3.3. OTHER NUCLEIC ACID ASSAYS
  • 7.4. CELL-BASED MULTIPLEX ASSAYS

8. MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. FLOW CYTOMETRY
  • 8.3. FLUORESCENCE DETECTION
  • 8.4. LUMINESCENCE
  • 8.5. MULTIPLEX REAL-TIME PCR
  • 8.6. OTHER TECHNOLOGIES

9. MULTIPLEX ASSAYS MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. RESEARCH & DEVELOPMENT
    • 9.2.1. DRUG DISCOVERY & DEVELOPMENT
    • 9.2.2. BIOMARKER DISCOVERY & VALIDATION
  • 9.3. CLINICAL DIAGNOSTICS
    • 9.3.1. INFECTIOUS DISEASES
    • 9.3.2. CANCER
    • 9.3.3. CARDIOVASCULAR DISEASES
    • 9.3.4. AUTOIMMUNE DISEASES
    • 9.3.5. NERVOUS SYSTEM DISORDERS
    • 9.3.6. METABOLISM & ENDOCRINOLOGY DISORDERS
    • 9.3.7. OTHER DISEASES

10. MULTIPLEX ASSAYS MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.3. HOSPITALS & RESEARCH INSTITUTES
  • 10.4. REFERENCE LABORATORIES
  • 10.5. OTHER END USERS

11. MULTIPLEX ASSAYS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. US
    • 11.2.2. CANADA
  • 11.3. EUROPE
  • 11.4. ASIA PACIFIC
  • 11.5. REST OF THE WORLD

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET RANKING ANALYSIS, 2017
  • 12.3. COMPETITIVE SITUATION AND TRENDS
    • 12.3.1. PRODUCT LAUNCHES AND APPROVALS
    • 12.3.2. COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS
    • 12.3.3. ACQUISITIONS

13. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 13.1. LUMINEX
  • 13.2. THERMO FISHER SCIENTIFIC
  • 13.3. ILLUMINA
  • 13.4. BIO-RAD LABORATORIES
  • 13.5. QIAGEN
  • 13.6. ABCAM
  • 13.7. BECTON DICKINSON AND COMPANY
  • 13.8. MERCK
  • 13.9. AGILENT TECHNOLOGIES
  • 13.10. MESO SCALE DIAGNOSTICS
  • 13.11. RANDOX LABORATORIES
  • 13.12. QUANTERIX
  • 13.13. BIO-TECHNE
  • 13.14. OLINK
  • 13.15. SEEGENE

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.5. AVAILABLE CUSTOMIZATIONS
  • 14.6. RELATED REPORTS
  • 14.7. AUTHOR DETAILS